Efficacy and safety of panitumumab alone or in association with radiotherapy in unresectable cutaneous squamous cell carcinoma-Reference-Cited by-同舟云学术

Efficacy and safety of panitumumab alone or in association with radiotherapy in unresectable cutaneous squamous cell carcinoma

Published:2020-08-24 Issue:12 Volume:34 Page:2789-2794
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Hourbeigt K.¹^ORCID,Ehret M.¹,Visseaux L.¹,Durlach A.²^ORCID,Petit A.¹,Sanchez J.¹,Grange‐Prunier A.¹,Barbe C.³^ORCID,Servagi‐Vernat S.⁴^ORCID,Grange F.¹^ORCID

Affiliation:

1. Department of Oncodermatology Reims University Hospital Reims France

2. Department of Biopathology Reims University Hospital Reims France

3. Methodological Support Unit Reims University Hospital Reims France

4. Department of Radiation Oncology Institut Jean Godinot Reims France

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.16465

Reference26 articles.

1. Cutaneous Squamous-Cell Carcinoma

2. Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

3. Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial

4. Phase II and Biologic Study of Interferon Alfa, Retinoic Acid, and Cisplatin in Advanced Squamous Skin Cancer

5. Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Advances and Challenges in the Management of Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients;Cancers;2024-09-10

2. Revolutionizing non‐melanoma skin cancer treatment: Receptor tyrosine kinase inhibitors take the stage;Journal of Cosmetic Dermatology;2024-05-29

3. Combining radiation and systemic therapy;Palliative Radiation Oncology;2024

4. Epidermal growth factor receptor inhibitors in advanced cutaneous squamous cell carcinoma: A systematic review and meta‐analysis;Experimental Dermatology;2023-11-16

5. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment–Update 2023;European Journal of Cancer;2023-11